Patel VH, Thannir S, Dhanani M, Augustine I, Sandeep SL, Mehadi A, et al
In the SURMOUNT-1 trial, Mounjaro helped people lose up to 22.5% of their starting body weight at 72 weeks
GLP-1 medications carry serious gastroparesis risks that extend far beyond commonly reported nausea and vomiting, requiring heightened clinical awareness and proactive management strategies
They found that the positive impact of GLP-1 RAs on overall health surpassed that of metformin, the most widely prescribed medication for people with type 2 diabetes, in most categories
Metabolon has created a suite of tools built from decades of experience across thousands of metabolomics studies to help you understand the crucial role of amino acid derivatives in disorders and pathways
Why Safe Use Matters for Long-Term Health The long-term safety and efficacy of semaglutide rely heavily on proper use